Topical Corticosteroids Do Not Revert the Activated Phenotype of Eosinophils in Eosinophilic Esophagitis but Decrease Surface Levels of CD18 Resulting in Diminished Adherence to ICAM-1, ICAM-2, and Endothelial Cells

Inflammation

Volumn 37, Issue 6, 2014, Pages 1932-1944

  Lingblom, Christine ^a   Bergquist, Henrik ^a   Johnsson, Marianne ^a   Sundström, Patrik ^a   Quiding Järbrink, Marianne ^a   Bove, Mogens ^b   Wennerås, Christine ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NÄL Hospital   (Sweden)

Author keywords

adhesion; CD18; corticosteroids; eosinophilic esophagitis; eosinophils; ICAM

Indexed keywords

CD18 ANTIGEN; CELL ADHESION MOLECULE; CORTICOSTEROID; ICAM2 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; BLOOD; DRUG EFFECTS; ENDOTHELIUM CELL; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHENOTYPE; TOPICAL DRUG ADMINISTRATION; UMBILICAL VEIN ENDOTHELIAL CELL; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD18; CELL ADHESION MOLECULES; ENDOTHELIAL CELLS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84937560422     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9926-x     Document Type: Article

References (47)

1. Attwood, S.E., T.C. Smyrk, T.R. Demeester, and J.B. Jones. 1993. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Digestive Diseases and Sciences 38: 109–116.
2. Schoepfer, A.M., D. Simon, and A. Straumann. 2011. Eosinophilic oesophagitis: latest intelligence. Clinical and Experimental Allergy 41: 630–639.
3. Liacouras, C.A., G.T. Furuta, et al. 2011. Eosinophilic esophagitis: updated consensus recommendations for children and adults. The Journal of Allergy and Clinical Immunology 128: 3–20.
4. Spergel, J.M. 2007. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Current Opinion in Allergy and Clinical Immunology 7: 274–278.
5. Rothenberg, M.E., A. Mishra, E.B. Brandt, and S.P. Hogan. 2001. Gastrointestinal eosinophils. Immunological Reviews 179: 139–155.
6. Straumann, A., M. Bauer, B. Fischer, K. Blaser, and H.U. Simon. 2001. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. The Journal of Allergy and Clinical Immunology 108: 954–961.
7. Tantibhaedhyangkul, U., N. Tatevian, M.A. Gilger, A.M. Major, and C.M. Davis. 2009. Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease. Annals of Clinical and Laboratory Science 39: 99–107.
8. Stein, M.L., M.H. Collins, J.M. Villanueva, et al. 2006. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. The Journal of Allergy and Clinical Immunology 118: 1312–1319.
9. Straumann, A., S. Conus, P. Grzonka, et al. 2010. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 59: 21–30.
10. Straumann, A., S. Conus, L. Degen, et al. 2010. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 139: 1526–1537. 1537 e1521.
11. Bergquist, H., H. Larsson, L. Johansson, and M. Bove. 2011. Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: a pilot study. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 145: 551–556.
12. Johnsson, M., M. Bove, H. Bergquist, et al. 2011. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. Journal of Innate Immunity 3: 594–604.
13. Dakkak, M., and J.R. Bennett. 1992. A new dysphagia score with objective validation. Journal of Clinical Gastroenterology 14: 99–100.
14. Svensson, L., C. Dahlgren, and C. Wenneras. 2002. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. Journal of Leukocyte Biology 72: 810–818.
15. Dahlgren, C., T. Christophe, F. Boulay, et al. 2000. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-Dmet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95: 1810–1818.
16. Roederer, M. 2002. Compensation in flow cytometry. Bethesda: Curr Protoc Cytom.
17. Svensson, L., E. Redvall, C. Bjorn, et al. 2007. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. European Journal of Immunology 37: 1966–1977.
18. Stenfeldt, A.L., and C. Wenneras. 2004. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 112: 605–614.
19. Eriksson, L., H. Antti, J. Gottfries, et al. 2004. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Analytical and Bioanalytical Chemistry 380: 419–429.
20. Trygg, J., and S. Wold. 2002. Orthogonal projections to latent structures (o-pls). Journal of Chemometrics 16: 119–128.
21. Woolley, K.L., P.G. Gibson, K. Carty, et al. 1996. Eosinophil apoptosis and the resolution of airway inflammation in asthma. American Journal of Respiratory and Critical Care Medicine 154: 237–243.
22. Prasad, G.A., N.J. Talley, Y. Romero, et al. 2007. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. American Journal of Gastroenterology 102: 2627–2632.
23. Liacouras, C.A., J.M. Spergel, E. Ruchelli, et al. 2005. Eosinophilic esophagitis: a 10-year experience in 381 children. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 3: 1198–1206.
24. Walsh, G.M., A. Hartnell, A.J. Wardlaw, et al. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 71: 258–265.
25. Johansson, M.W., D.S. Annis, and D.F. Mosher. 2013. Alpha(m)beta(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. American Journal of Respiratory Cell and Molecular Biology 48: 503–510.
26. Blanchard, C., N. Wang, K.F. Stringer, et al. 2006. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. The Journal of Clinical Investigation 116: 536–547.
27. Blanchard, C., M.K. Mingler, M. McBride, et al. 2008. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunology 1: 289–296.
28. Gleich, G.J., and C.R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Advances in Immunology 39: 177–253.
29. Schaefer, E.T., J.F. Fitzgerald, J.P. Molleston, et al. 2008. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 6: 165–173.
30. Meagher, L.C., J.M. Cousin, J.R. Seckl, and C. Haslett. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. Journal of Immunology 156: 4422–4428.
31. Trull, A.K., L.A. Steel, L.D. Sharples, et al. 2000. Randomized trial of blood eosinophil count monitoring as a guide to corticosteroid dosage adjustment after heart transplantation. Transplantation 70: 802–809.
32. Torsteinsdottir, I., N.G. Arvidson, R. Hallgren, and L. Hakansson. 1999. Enhanced expression of integrins and CD66B on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids. Scandinavian Journal of Immunology 50: 433–439.
33. Hartnell, A., A.B. Kay, and A.J. Wardlaw. 1992. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone. Immunology 77: 488–493.
34. Sale, R., F. Sabatini, M. Silvestri, et al. 2004. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis. International Immunopharmacology 4: 1687–1696.
35. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. Journal of Leukocyte Biology 67: 2–17.
36. MacDonald, A.S., A.D. Straw, N.M. Dalton, and E.J. Pearce. 2002. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. Journal of Immunology 168: 537–540.
37. Le-Carlson, M., S. Seki, D. Abarbanel et al. 2012. Markers of antigen presentation and activation on eosinophils and T-cells in the esophageal tissue of patients with eosinophilic esophagitis. Journal of Pediatric Gastroenterology and Nutrition
38. Zhang, Z., T.J. Sferra, and Y. Eroglu. 2013. T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Digestive Diseases and Sciences 58: 1497–1506.
39. Akuthota, P., H.B. Wang, L.A. Spencer, and P.F. Weller. 2008. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clinical and Experimental Allergy 38: 1254–1263.
40. Ohkawara, Y., K.G. Lim, Z. Xing, et al. 1996. CD40 expression by human peripheral blood eosinophils. The Journal of Clinical Investigation 97: 1761–1766.
41. Bureau, F., G. Seumois, F. Jaspar, et al. 2002. CD40 engagement enhances eosinophil survival through induction of cellular inhibitor of apoptosis protein 2 expression: possible involvement in allergic inflammation. The Journal of Allergy and Clinical Immunology 110: 443–449.
42. Bullock, J.Z., J.M. Villanueva, C. Blanchard, et al. 2007. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. Journal of Pediatric Gastroenterology and Nutrition 45: 22–31.
43. Lucendo, A.J., and M. Sanchez-Cazalilla. 2012. Adult versus pediatric eosinophilic esophagitis: important differences and similarities for the clinician to understand. Expert Review of Clinical Immunology 8: 733–745.
44. Straumann, A., S.S. Aceves, C. Blanchard, et al. 2012. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 67: 477–490.
45. Zimmermann, N., J.J. Conkright, and M.E. Rothenberg. 1999. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. The Journal of Biological Chemistry 274: 12611–12618.
46. Zimmermann, N., and M.E. Rothenberg. 2003. Receptor internalization is required for eotaxin-induced responses in human eosinophils. The Journal of Allergy and Clinical Immunology 111: 97–105.
47. Farahi, N., N.R. Singh, S. Heard, et al. 2012. Use of 111-indium-labeled autologous eosinophils to establish the in vivo kinetics of human eosinophils in healthy subjects. Blood 120: 4068–4071.